United States · FDA National Drug Code directory

Excedrin Migraine Relief

A source-listed medicine record.

Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.

Medicine identity

Source reference
0067-2042_27f2895c-750b-4c97-9d33-914f4df59bd2
Product NDC
0067-2042
Form
TABLET, FILM COATED
Composition / generic term
Acetaminophen, Aspirin (NSAID), Caffeine
Labeler
Haleon US Holdings LLC
Marketing category
NDA
Marketing start / end (source format)
20240101
Source listing expiry
20261231

Source-listed ingredients

  • ACETAMINOPHEN — 250 mg/1
  • ASPIRIN — 250 mg/1
  • CAFFEINE — 65 mg/1

These values do not establish equivalence or a dose recommendation.

Packages

  • 1 BOTTLE in 1 CARTON (0067-2042-01) / 24 TABLET, FILM COATED in 1 BOTTLE · 0067-2042-01
  • 1 BOTTLE in 1 CARTON (0067-2042-02) / 30 TABLET, FILM COATED in 1 BOTTLE · 0067-2042-02
  • 1 BOTTLE in 1 CARTON (0067-2042-03) / 50 TABLET, FILM COATED in 1 BOTTLE · 0067-2042-03
  • 1 BOTTLE in 1 CARTON (0067-2042-04) / 100 TABLET, FILM COATED in 1 BOTTLE · 0067-2042-04
  • 1 BOTTLE in 1 CARTON (0067-2042-05) / 125 TABLET, FILM COATED in 1 BOTTLE · 0067-2042-05
  • 1 BOTTLE in 1 CARTON (0067-2042-06) / 200 TABLET, FILM COATED in 1 BOTTLE · 0067-2042-06
  • 1 BOTTLE in 1 CARTON (0067-2042-07) / 250 TABLET, FILM COATED in 1 BOTTLE · 0067-2042-07
  • 300 TABLET, FILM COATED in 1 BOTTLE (0067-2042-08) · 0067-2042-08

Source and coverage

Open FDA National Drug Code directory →

Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.

Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.

Browse United States records →